Varicella zoster virus vaccine live - El-Shaddai

Drug Profile

Varicella zoster virus vaccine live - El-Shaddai

Alternative Names: Chickenpox vaccine - El-Shaddai

Latest Information Update: 03 Jun 2015

Price : $50

At a glance

  • Originator El-Shaddai Biologicals
  • Class Varicella vaccines; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Varicella zoster virus infections

Most Recent Events

  • 03 Jun 2015 No recent reports on development identified - Phase-III for Varicella zoster virus infections (In children, In infants, Prevention) in India (SC)
  • 22 Dec 2011 El-Shaddai completes a phase III trial in Varicella zoster virus infections (prevention, in children and infants) in India (CTRI/2011/06/001787)
  • 15 Jun 2011 Phase-III clinical trials in Varicella zoster virus infections (prevention, in children and infants) in India (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top